1
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Li J, Huang L, Liu CF, Cao J, Yan JJ, Xu
F, Wu MC and Yan YQ: Risk factors and surgical outcomes for
spontaneous rupture of BCLC stages A and B hepatocellular
carcinoma: A case-control study. World J Gastroenterol.
20:9121–9127. 2014.PubMed/NCBI
|
4
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Teoh NC: Proliferative drive and liver
carcinogenesis: Too much of a good thing? J Gastroenterol Hepatol.
24:1817–1825. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Levine AJ, Momand J and Finlay CA: The p53
tumour suppressor gene. Nature. 351:453–456. 1991. View Article : Google Scholar : PubMed/NCBI
|
8
|
Perkins ND: The diverse and complex roles
of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132.
2012.PubMed/NCBI
|
9
|
Greten FR and Karin M: The IKK/NF-kappaB
activation pathway-a target for prevention and treatment of cancer.
Cancer Lett. 206:193–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Karin M and Greten FR: NF-kappaB: Linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Deberardinis RJ, Sayed N, Ditsworth D and
Thompson CB: Brick by brick: Metabolism and tumor cell growth. Curr
Opin Genet Dev. 18:54–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lingwood D and Simons K: Lipid rafts as a
membrane-organizing principle. Science. 327:46–50. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Simons K and Ikonen E: Functional rafts in
cell membranes. Nature. 387:569–572. 1997. View Article : Google Scholar : PubMed/NCBI
|
14
|
Pettus BJ, Chalfant CE and Hannun YA:
Ceramide in apoptosis: An overview and current perspectives.
Biochim Biophys Acta. 1585:114–125. 2002. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hannun YA and Obeid LM: Principles of
bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol
Cell Biol. 9:139–150. 2008. View
Article : Google Scholar : PubMed/NCBI
|
16
|
Mizutani Y, Mitsutake S, Tsuji K, Kihara A
and Igarashi Y: Ceramide biosynthesis in keratinocyte and its role
in skin function. Biochimie. 91:784–790. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Reynolds CP, Maurer BJ and Kolesnick RN:
Ceramide synthesis and metabolism as a target for cancer therapy.
Cancer Lett. 206:169–180. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
White-Gilbertson S, Mullen T, Senkal C, Lu
P, Ogretmen B, Obeid L and Voelkel-Johnson C: Ceramide synthase 6
modulates TRAIL sensitivity and nuclear translocation of active
caspase-3 in colon cancer cells. Oncogene. 28:1132–1141. 2009.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Livak KJ and Schmitggen TD: Analysis of
relative gene expression data using real-time quantitiative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Schiffmann S, Sandner J, Birod K, Wobst I,
Angioni C, Ruckhäberle E, Kaufmann M, Ackermann H, Lötsch J,
Schmidt H, et al: Ceramide synthases and ceramide levels are
increased in breast cancer tissue. Carcinogenesis. 30:745–752.
2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Reynolds CP, Maurer BJ and Kolesnick RN:
Ceramide synthesis and metabolism as a target for cancer therapy.
Cancer Lett. 206:169–180. 2004. View Article : Google Scholar : PubMed/NCBI
|